Telik Inc Quick Ratio (TELK) starting from the first quarter 2018 to first quarter 2013, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Telik Inc  (TELK)

Telik Inc's Quick Ratio

TELK's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the first quarter 2018, Quick Ratio fell to 0.17 a new company low.

Within Biotechnology & Pharmaceuticals industry 79 other companies have achieved higher Quick Ratio than Telik Inc in first quarter 2018. While Quick Ratio total ranking in the first quarter 2018 has deteriorated compared to the prior quarter from to 3622.

Explain Quick Ratio?
How much Cash & cash equivalents TELK´s has?
What are TELK´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TELK Quick Ratio (Mar 31 2018)
Q1		 (Jun 30 2014)
Q2		 (Mar 31 2014)
Q1		 (Dec 31 2013)
Q4		 (Sep 30 2013)
Q3
Y / Y Current Liabilities Change 381.86 % -19.73 % -70.48 % -95.9 % 163.1 %
Y / Y Cash & cash equivalent Change -66.96 % -53.6 % -77.44 % -60.68 % -69.11 %
Quick Ratio MRQ 0.17 2.04 3.13 6.12 2.55
TELK's Total Ranking # 3622 # # # #
Seq. Current Liabilities Change 504.14 % 147.16 % 11.26 % -71 % 0.64 %
Seq. Cash & cash equivalent Change -48.4 % 61.56 % -43.16 % -30.28 % -27.54 %



Quick Ratio first quarter 2018 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 80
Healthcare Sector # 590
Overall Market # 3622


Quick Ratio Statistics
High Average Low
21.7 8.07 0.17
(Sep 30 2012)   (Mar 31 2018)




Financial Statements
Telik Inc's Current Liabilities $ 6 Millions Visit TELK's Balance sheet
Telik Inc's Cash & cash equivalent $ 1 Millions Visit TELK's Balance sheet
Source of TELK's Sales Visit TELK's Sales by Geography


Cumulative Telik Inc's Quick Ratio

TELK's Quick Ratio for the trailling 12 Months

TELK Quick Ratio

 (Mar 31 2018)
12 Months		 (Jun 30 2014)
12 Months		 (Mar 31 2014)
12 Months		 (Dec 31 2013)
12 Months		 (Sep 30 2013)
12 Months
Y / Y Current Liabilities TTM Growth -38.72 % -74.75 % -70.69 % -58.87 % 213.8 %
Y / Y Cash & cash equivalent TTM Growth -65.07 % -66.45 % -62.6 % -52.96 % -51.1 %
Quick Ratio TTM 0.84 2.89 3.39 3.65 1.48
Total Ranking TTM # 3519 # # # #
Seq. Current Liabilities TTM Growth 158.43 % -7.52 % -22.82 % -66.78 % 6.5 %
Seq. Cash & cash equivalent TTM Growth -24.49 % -21.3 % -28.15 % -18.2 % -27.46 %

Quick ratio ranking by company, industry and sector >> Back to TELK Financial Strength Comparisons >> Go to Compare TELK Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q1 2018 to $6.05 millions, cumulative Quick Ratio decreased to 0.84 below the Telik Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 57 other companies have achieved higher Quick Ratio than Telik Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2014 from to 3519.

Explain Quick Ratio?
How much Cash & cash equivalents TELK´s has?
What are TELK´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 58
Healthcare Sector # 443
Within the Market # 3519


trailing twelve months Quick Ratio Statistics
High Average Low
3.79 2.89 2.08
(Sep 30 2013)   (Jun 30 2014)




Companies with similar Quick Ratio in the quarter ending Mar 31 2018, within Biotechnology & Pharmaceuticals Industry Quick RatioMar 31 2018 MRQ Cash & cash equivalentMar 31 2018 MRQ Current Liabilities
Sorrento Therapeutics Inc   0.48 $ 24.696  Millions$ 51.524  Millions
Cel sci Corporation  0.44 $ 4.733  Millions$ 10.857  Millions
Agentix Corp   0.31 $ 0.002  Millions$ 0.005  Millions
Outlook Therapeutics Inc   0.19 $ 5.936  Millions$ 31.752  Millions
Telik Inc  0.17 $ 1.056  Millions$ 6.047  Millions
Windtree Therapeutics Inc  0.15 $ 1.854  Millions$ 12.064  Millions
Champions Oncology Inc   0.11 $ 0.856  Millions$ 7.453  Millions
Cannabis Global Inc.  0.04 $ 0.005  Millions$ 0.113  Millions
Premier Biomedical Inc  0.04 $ 0.079  Millions$ 2.126  Millions

Date modified: 2026-09-02T18:05:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.